Healthcare - Biotechnology - NASDAQ - US
$ 15.83
-5.72 %
$ 1.35 B
Market Cap
-4.31
P/E
Price Target
Average
105.31%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.12%
Net Income
Estimate
33.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Syndax Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SNDX of $32.5 , with forecasts ranging from a low of $18 to a high of $40 .
SNDX Lowest Price Target
Wall Street Target
18 USD
13.71%
SNDX Average Price Target
Wall Street Target
32.5 USD
105.31%
SNDX Highest Price Target
Wall Street Target
40 USD
152.68%
REVENUE FORECAST
Revenue Forecast Chart SNDX
EBIT FORECAST
EBIT Forecast Chart SNDX
NET INCOME FORECAST
Net Income Chart SNDX